Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-14

Clinical Trial Update: Send-In Sample Collection to Achieve Genetic and Immunologic Characterization of Primary Immunodeficiencies

View source ↗

Summary

This study involves send-in sample collection to genetically and immunologically characterize primary immunodeficiencies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Primary Immunodeficiency | Status: RECRUITING